Assessment of β-cell function in human patients

Islets

Volumn 4, Issue 2, 2012, Pages 79-83

  Choi, CheolSoo ^a   Kim, MiYeon ^b   Han, Kyungreem ^b   Lee, Myung Shik ^b,c  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Glucose clamp technique; Glucose tolerance test; Insulin resistance; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCOSE;

CLINICAL PRACTICE; DIABETIC PATIENT; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOMEOSTATIC MODEL ASSESSENT; HUMAN; IN VIVO STUDY; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MINIMAL MODEL; MODEL; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; REVIEW;

EID: 84862160723     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.19270     Document Type: Review

References (39)

1. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004; 88:787-835; PMID:15308380; http://dx.doi.org/10.1016/j.mcna.2004.04.013.
2. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46:3-19; PMID:12637977.
3. Nielsen JH, Galsgaard ED, Møldrup A, Friedrichsen BN, Billestrup N, Hansen JA, et al. Regulation of beta-cell mass by hormones and growth factors. Diabetes 2001; 50:25-9; PMID:11272193; http://dx.doi.org/10.2337/ diabetes.50.2007.S25.
4. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104:787-94; PMID:10491414; http://dx.doi.org/10.1172/JCI7231.
5. Rubenstein AH, Pottenger LA, Mako M, Getz GS, Steiner DF. The metabolism of proinsulin and insulin by the liver. J Clin Invest 1972; 51:912-21; PMID:5014618; http://dx.doi.org/10.1172/JCI106886.
6. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9; PMID:3899825; http://dx.doi.org/10.1007/BF00280883.
7. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 1999; 259:3-17; PMID:9914469; http://dx.doi.org/10.1046/j.1432-327.1999.00043.x.
8. Suckale J, Solimena M. The insulin secretory granule as a signaling hub. Trends Endocrinol Metab 2010; 21:599-609; PMID:20609596; http://dx.doi.org/10. 1016/j.tem.2010.06.003.
9. Wang Z, Thurmond DC. Mechanisms of biphasic insulin-granule exocytosis-roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci 2009; 122:893-903; PMID:19295123; http://dx.doi.org/10.1242/jcs.034355.
10. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP. Successful islet auto-transplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998; 47:324-30; PMID:9519735; http://dx.doi.org/10.2337/diabetes.47.3.324.
11. Bergman RN. Minimal model: perspective from 2005. Horm Res 2005; 64:8-15; PMID:16439839; http://dx.doi.org/10.1159/000089312.
12. Pfeifer MA, Graf RJ, Halter JB, Porte D Jr. The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man. Diabetologia 1981; 21:198-205; PMID:7028551; http://dx.doi.org/ 10.1007/BF00252654.
13. Pfeifer MA, Halter JB, Beard JC, Porte D Jr. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1981; 53:1256-62; PMID:7028776; http://dx.doi.org/10.1210/jcem-53-6-1256.
14. Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 1980; 29:979-90; PMID:7002673; http://dx.doi.org/10.2337/diabetes.29.12.979.
15. Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007; 293:1-15; PMID:17341552; http://dx.doi.org/10. 1152/ajpendo.00421.2006.
16. Toffolo G, Cefalu WT, Cobelli C. Beta-cell function during insulin-modified intravenous glucose tolerance test successfully assessed by the C-peptide minimal model. Metabolism 1999; 48:1162-6; PMID:10484058; http://dx.doi.org/10.1016/S0026-0495(99)90132-4.
17. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes 2002; 51:2170-8; PMID:12086947; http://dx.doi.org/10.2337/diabetes. 51.7.2170.
18. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32:335-41; PMID:18957530; http://dx.doi.org/10.2337/dc08-1478.
19. Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med 2008; 25:671-7; PMID:18544104; http://dx.doi.org/10.1111/j.1464-5491.2008. 02441.x.
20. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005; 90:493-500; PMID:15483086; http://dx.doi.org/10.1210/jc.2004-1133.
21. Han MS, Chung KW, Cheon HG, Rhee SD, Yoon CH, Lee MK, et al. Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice. Diabetes 2009; 58:329-36; PMID:19171749; http://dx.doi.org/10. 2337/db08-0080.
22. Salehi A, Chen D, Håkanson R, Nordin G, Lundquist I. Gastrectomy induces impaired insulin and glucagon secretion: evidence for a gastro-insular axis in mice. J Physiol 1999; 514:579-91; PMID:9852337; http://dx.doi.org/10. 1111/j.1469-7793.1999.579ae.x.
23. Yasuhara D, Naruo T, Nagai N, Tanaka M, Muranaga T, Nozoe S. Insulinogenic index at 15 min as a marker of nutritional rehabilitation in anorexia nervosa. Am J Clin Nutr 2003; 77:292-9; PMID:12540385.
24. Hovorka R, Jones RH. How to measure insulin secretion. Diabetes Metab Rev 1994; 10:91-117; PMID:7956679; http://dx.doi.org/10.1002/dmr.5610100204.
25. Tura A, Pacini G, Kautzky-Willer A, Gastaldelli A, Defronzo RA, Ferrannini E, et al. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models. Metabolism 2012; 61:434-43; PMID:21944265; http://dx.doi.org/10.1016/j.metabol.2011.08.001.
26. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992; 41:368-77; PMID:1551497; http://dx.doi.org/10.2337/diabetes.41.3.368.
27. Sparacino G, Cobelli C. A stochastic deconvolution method to reconstruct insulin secretion rate after a glucose stimulus. IEEE Trans Biomed Eng 1996; 43:512-29; PMID:8849464; http://dx.doi.org/10.1109/10.488799.
28. Breda E, Cobelli C. Insulin secretion rate during glucose stimuli: alternative analyses of C-peptide data. Ann Biomed Eng 2001; 29:692-700; PMID:11556725; http://dx.doi.org/10.1114/1.1385804.
29. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:214-23; PMID:382871.
30. Choi CS, Kim C, Lee WJ, Park JY, Hong SK, Lee MG, et al. Association between birth weight and insulin sensitivity in healthy young men in Korea: role of visceral adiposity. Diabetes Res Clin Pract 2000; 49:53-9; PMID:10808063; http://dx.doi.org/10.1016/S0168-8227(00)00131-5.
31. Davies MJ, Rayman G, Grenfell A, Gray IP, Day JL, Hales CN. Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabet Med 1994; 11:432-6; PMID:8088119; http://dx.doi.org/10.1111/j.1464-5491.1994.tb00302.x.
32. Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 2002; 51:117-21; PMID:11815469; http://dx.doi.org/10.2337/diabetes.51.2007.S117.
33. Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966; 45:1487-502; PMID:5919350; http://dx.doi.org/10.1172/JCI105456.
34. Matthews DR, Boland O. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state. Metabolism 1997; 46:5-9; PMID:9439551; http://dx.doi.org/10.1016/S0026-0495(97)90309-7.
35. Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Halter JB. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes 1997; 46:1749-54; PMID:9356021; http://dx.doi.org/10.2337/diabetes.46. 11.1749.
36. van Loon LJ, Saris WH, Verhagen H, Wagenmakers AJ. Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. Am J Clin Nutr 2000; 72:96-105; PMID:10871567.
37. Ozbek M, Erdogan M, Karadeniz M, Cetinkalp S, Ozgen AG, Saygili F, et al. Evaluation of beta cell dysfunction by mixed meal tolerance test and oral L-arginine in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2009; 117:573-6; PMID:19924604; http://dx.doi.org/10.1055/s- 0029-1234087.
38. Rijkelijkhuizen JM, McQuarrie K, Girman CJ, Stein PP, Mari A, Holst JJ, et al. Effects of meal size and composition on incretin, alpha-cell and beta-cell responses. Metabolism 2010; 59:502-11; PMID:19846181; http://dx.doi.org/10.1016/j.metabol.2009.07.039.
39. Mari A, Tura A, Gastaldelli A, Ferrannini E. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 2002; 51:221-6; PMID:11815483; http://dx.doi.org/10.2337/diabetes.51.2007.S221.